GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » 3-Year ROIIC %

Biomark Diagnostics (FRA:20B) 3-Year ROIIC % : -19.34% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Biomark Diagnostics's 3-Year ROIIC % for the quarter that ended in Mar. 2024 was -19.34%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Biomark Diagnostics's 3-Year ROIIC % or its related term are showing as below:

FRA:20B's 3-Year ROIIC % is ranked worse than
61.54% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.94 vs FRA:20B: -19.34

Biomark Diagnostics 3-Year ROIIC % Historical Data

The historical data trend for Biomark Diagnostics's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics 3-Year ROIIC % Chart

Biomark Diagnostics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -962.16 -60.10 -43.57 -19.34

Biomark Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -19.34 - -

Competitive Comparison of Biomark Diagnostics's 3-Year ROIIC %

For the Diagnostics & Research subindustry, Biomark Diagnostics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's 3-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's 3-Year ROIIC % falls into.



Biomark Diagnostics 3-Year ROIIC % Calculation

Biomark Diagnostics's 3-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.895 (Mar. 2024) - -0.724 (Mar. 2021) )/( 0.849 (Mar. 2024) - 0.026 (Mar. 2021) )
=-0.171/0.823
=-20.78%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Biomark Diagnostics  (FRA:20B) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Biomark Diagnostics 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Biomark Diagnostics Headlines

No Headlines